Aller au contenu

Publications scientifiques

  • article Gorman M, Usmani N, Pollak MN, Ghosh S, Elangovan A, Kim J, Thoms J, Bouchard M, Peacock M, Wang Y, Fleshner NE, Campbell H, Vigneault E, Vincent F, So A, Cury FL, Quon HC, Carlson RG, Lambert C, Klotz L, Chi K, Brundage M, Courneya KS, Eigl BJ

    Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer

    Endocr Oncol 6 (1), 2026.

    DOI PUBMED
  • article Fabi F, Crook J, Jolicoeur M, Rauth S, Koll W, Tisseveransinghe S, Ebacher A, Niazi T, Duplan D, Bernard AA, Vavassis P, Foster W, Vigneault É and Archambault L, Beaulieu L, Lavallée MC, Lacroix F, Carignan D, Martin AG

    Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional no…

    Radiother Oncol 221 2026.

    DOI PUBMED
  • article Giguère P, Bahig H, Westra S, Roberge D, Bourque JM, Masucci GL, Nkurunziza ES, Freire V, Belliveau C, Duplan D, Vigneault E, Wong P, Lang P, Ménard C

    Platform for the Evaluation of innovations in Radiation oncology through registry-based conduct of multi-centric pragmatic randomized trials: PERa implementation

    Trials 27 (1), 2026.

    DOI PUBMED
  • article Dionne P, Martin AG, Ouellet É and Roy JC, Sidibé I, Froment MA, Vigneault É and Foster W, Bachand F, Archambault L, Poulin É

    Assessing inter-observer variability in prostate and GTV segmentation on mpMRI: A comparison between radiation oncologists and AI-based method

    J Appl Clin Med Phys 27 (4), 2026.

    DOI PUBMED
  • article Sidibé I, Beaudry MM, Carignan D, Froment MA, Foster W, Bachand F, Vigneault E, Magnan S, Aubin S, Morrier J, Poulin E, Lacroix F, Lavallée MC, Beaulieu L, Martin AG

    Ultra-hypofractionated radiotherapy combined with HDR brachytherapy: An optimized treatment

    Radiother Oncol 214 2026.

    DOI PUBMED
  • article Iorio-Duval C, Bélanger C, Vigneault É and Beaulieu L

    Retrospective evaluation of high-dose-rate brachytherapy multicriteria planning using physical dose versus radiobiological criteria for prostate cancer

    Sci Rep 16 (1), 2026.

    DOI PUBMED
  • article Eigl BJ, Elangovan A, Ghosh S, Kim JO, Thoms J, Bouchard M, Peacock M, Fleshner N, Campbell H, Vigneault E, Vincent F, So A, Cury F, Quon H, Carlson R, Lambert C, Klotz L, Chi K, Brundage M, Pollak M, Rebane L, Chiu L, Courneya KS, Usmani N

    A Randomized Phase 3 Trial of Metformin in Patients Initiating Androgen Deprivation Therapy as Prevention and Intervention of Metabolic Syndrome: The PRIME Study

    J Urol 214 (5), 2025.

    DOI PUBMED
  • article Mansour IR, Miksys N, Beaulieu L, Vigneault É and Thomson RM

    Haralick texture feature analysis for Monte Carlo dose distributions of permanent implant prostate brachytherapy

    Brachytherapy 24 (1), 2025.

    DOI PUBMED
  • article Moghadam N, Akbari F, Zhang C, Ouellet S, McKeown D, Hoseini-Ghahfarokhi M, Parent S, Carrier JF, Lavallée MC, Cygler JE, Hilts M, Vigneault E, Crook J, Beaulieu L, Thomson RM

    Clinical implementation of an open-source Monte Carlo system across multiple centers for permanent implant brachytherapy dose evaluation

    Brachytherapy 24 (5), 2025.

    DOI PUBMED
  • article So AI, Chi K, Danielson B, Fleshner N, Kinnaird A, Niazi T, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, Vigneault E, Breau RH, Saad F

    2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castration-sensitive prostate cancer (Update)

    Can Urol Assoc J 19 (5), 2025.

    DOI PUBMED
  • article Saad F, So AI, Aprikian A, Finelli A, Fleshner NE, Gleave ME, Hamilou Z, Niazi T, North SA, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, Usmani N, Vigneault E, Chi KN

    2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-resistant prostate cancer (Update)

    Can Urol Assoc J 19 (8), 2025.

    DOI PUBMED
  • article Martell K, Keyes M, Wiebe E, Vigneault E, Taggar A

    The Canadian brachytherapy experience: Results of the Canadian brachytherapy group national survey

    Brachytherapy 24 (5), 2025.

    DOI PUBMED